CERo Therapeutics (CERO)

• Market cap: $3.51M
• 1 day: -1.57%
• 5 days: -26.56%
• 1 month: -64.19%
• 3 months: -74.93%
• 6 months: -89.84%
• Year to date: -98.46%
• 1 year: -98.76%
• 5 years: -99.99%
• 10 years: -99.99%
• Sector: Healthcare
• Industry: Biotechnology

About: CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

Employees: 8